C9orf72 and amyotrophic lateral sclerosis: However, population studies have suggested that up to 0.2–0.6% of the North European population may in fact carry the C9orf72 expansion, a carrier frequency far in excess of what would be expected and one similar to the overall lifetime risk of developing ALS [22,23].